Polymorphism in the oxytocin promoter region in patients with lactase non-persistence is not related to symptoms

BMC Gastroenterology

Volumn 9, Issue , 2009, Pages

  Truedsson, Mikael ^a   Carlson, Joyce ^a   Simrén, Magnus ^b   Ohlsson, Bodil ^a  

^a LUND UNIVERSITY   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; LACTASE; OXYTOCIN; OXYTOCIN RECEPTOR;

ADULT; AGED; ARTICLE; BLOOD DONOR; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; GASTROINTESTINAL SYMPTOM; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; ALLELE; BREATH ANALYSIS; CLINICAL TRIAL; COMPARATIVE STUDY; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MIDDLE AGED; MULTICENTER STUDY;

ADULT; AGED; ALLELES; BREATH TESTS; DNA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; IRRITABLE BOWEL SYNDROME; LACTASE; MALE; MIDDLE AGED; OXYTOCIN; POLYMORPHISM, GENETIC; YOUNG ADULT;

EID: 71949118414     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-9-90     Document Type: Article

References (39)

1. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006, 130:1480-1491. 10.1053/j.gastro.2005.11.061, 16678561.
2. Anthoni SR, Raspinerä HA, Kotamies AJ, Komu HA, Phlajamäki HK, Kolho KL, Järvelä IE. Molecularly defined adult-type hypolactasia among working age people with reference to milk consumption and gastrointestinal symptoms. World J Gastroenterol 2007, 13:1230-1235.
3. Bernardes-Silva CF, Pereira AC, de Fátima Alves da Mota G, Krieger JE, Laudanna AA. Lactase persistence/non-persistence variants, C/T_13910 and G/A_2 as a diagnostic tool for lactose intolerance in IBS patients. Clin Chim Acta 2018, 386:7-11.
4. Lomer MC, Parkes GC, Sanderson JD. Review article: lactose intolerance in clinical practice--myths and realities. Aliment Pharmacol Ther 2008, 27:93-103.
5. Cavalli-Sforza LT, Strata A. Double-blind study on the tolerance of four types of milk in lactose malabsorbers and absorbers. Clinical Nutrition 1986, 40c:19-30.
6. Stefano Di M, Miceli E, Mazzocchi S, Tana P, Moroni F, Corazza GR. Visceral hypersensitivity and intolerance symptoms in lactose malabsorption. Neurogastroenterol Motil 2007, 19:887-895. 10.1111/j.1365-2982.2007.00973.x, 17973635.
7. Camilleri M, Atanasova E, Carlson PJ, Ahmad U, Kim HJ, Viramontes BE, McKinzie S, Urrutia R. Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome. Gastroenterology 2002, 123:425-432. 10.1053/gast.2002.34780, 12145795.
8. Kim HJ, Camilleri M, Carlson PJ, Cremonini F, Ferber I, Stephens D, McKinzie S, Zinsmeister AR, Urrutia R. Association of distinct α2 adrenoceptor and serotonin transporter polymorphisms with constipation and somatic symptoms in functional gastrointestinal disorders. Gut 2006, 53:829-837.
9. Park JM, Choi MG, Park JA, OH JH, Cho YK, Lee IS, Kim SW, Choi KY, Chung IS. Serotonin transporter gene polymorphism and irritable bowel syndrome. Neurogastroenterol Motil 2006, 18:995-1000. 10.1111/j.1365-2982.2006.00829.x, 17040410.
10. Monstein H-J, Grahn N, Truedsson M, Ohlsson B. Oxytocin and oxytocin receptor mRNA expression in the human gastrointestinal tract: A polymerase chain reaction study. Reg Pept 2004, 119:39-44.
11. Ohlsson B, Truedsson M, Djerf P, Sundler F. Oxytocin is present throughout the human gastrointestinal tract. Reg Pept 2006, 135:7-11.
12. Ohlsson B, Forsling ML, Rehfeld JF, Sjölund K. Cholecystokinin leads to increased oxytocin secretion in healthy women. Eur J Surg 2002, 168:114-118. 10.1080/11024150252884340, 12113268.
13. Ohlsson B, Ringström G, Abrahamsson H, Simrén M, Björnsson ES. Oxytocin stimulates colonic motor activity in healthy women. Neurogastroenterol Mot 2004, 16:233-240.
14. Hashmonai M, Torem S, Argov S, Barzilai A, Schramek A. Prolonged post-vagotomy gastric atony treated by oxytocin. Br J Surg 1979, 66:550-551. 10.1002/bjs.1800660809, 486913.
15. Petring OU. The effect of oxytocin on basal and pethidine-induced delayed gastric emptying. Br J Clin Pharmacol 1989, 28:329-332. 1379952, 2789927.
16. Ohlsson B, Björgell O, Ekberg O, Darwiche G. The oxytocin/vasopressin receptor antagonist atosiban delays the gastric emptying of a semisolid meal compared to saline in human. BMC Gastroenterology 2006, 6:11. 1434749, 16542457, 10.1186/1471-230X-6-11.
17. Borg J, Melander O, Johansson L, Uvnäs-Moberg K, Rehfeld JF, Ohlsson B. Gastroparesis is associated with oxytocin deficiency, oesophageal dysmotility with hyperCCKemia and autonomic neuropathy with hypergastrinemia. BMC Gastroenterology 2009, 9:17. 2650701, 19243587, 10.1186/1471-230X-9-17.
18. Rao VV, Löffler C, Battey J, Hansmann I. The human gene for oxytocin-neurophysin I (OXT) is physically mapped to chromosome 20p13 by in situ hybridization. Cytogenet Cell Genet 1992, 61:271-273. 10.1159/000133420, 1486803.
19. Inoue T, Kimura T, Azuma C, Inazawa J, Takemura M, Kikuchi T, Kubota Y, Ogita K, Saji F. Structural organization of the human oxytocin receptor gene. J Biol Chem 1994, 269:32451-32456.
20. Entrez SNP [cited 2008 April]. , http://www.ncbi.nlm.nih.gov/
21. HapMap genome browser [cited 2008 April]. , http://www.hapmap.org
22. Bond JH, Levitt MD. Quantitative measurement of lactose absorption. Gastroenterology 1976, 70:1058-1062.
23. Nilsson TK, Olsson LA. Simultaneous genotyping of the three lactose tolerance-linked polymorhisms LCT-13907C>G, LCT-13910C>T and LCT-13915T>G with pyrosequencing technology. Clin Chem Lab Med 2008, 46:80-84. 10.1515/CCLM.2008.015, 18034639.
24. Wu CL, Hung CR, Chang FY, Pau KY, Wang JL, Wang PS. Involvement of cholecystokinin receptor in the inhibition of gastric emptying by oxytocin in male rats. Pflugers Arch 2002, 445:187-193. 10.1007/s00424-002-0925-7, 12457239.
25. Xie DP, Chen LB, Liu CY, Liu JZ, Liu KJ. Effect of oxytocin on contraction of rabbit proximal colon in vitro. World J Gastroenterol 2003, 9:165-168.
26. Xie D, Chen L, Liu C, Liu K. The inhibitory effects of oxytocin on distal colonic contractile activity in rabbits are enhanced by ovarian steroids. Acta Physiol 2006, 186:141-149.
27. Louvel D, Delvaux M, Felez A, Fioramonti J, Bueno L, Lazorthes Y, Frexinos J. Oxytocin increases thresholds of colonic visceral perception in patients with irritable bowel syndrome. Gut 1969, 39:741-747.
28. Uvnäs-Moberg K, Bruzelius G, Alster P, Bilevicinte I, Lundeberg T. Oxytocin increases and a specific oxytocin antagonist decreases pain threshold in male rats. Acta Physiol Scand 1992, 144:487-488. 10.1111/j.1748-1716.1992.tb09327.x, 1605050.
29. Ohlsson B, Truedsson M, Bengtsson M, Torstensson R, Sjölund K, Björnsson ES, Simrèn M. Effects of long-term treatment with oxytocin in chronic constipation; a double blind, placebo-controlled pilot trial. Neurogastroenterol Motil 2005, 17:697-704. 10.1111/j.1365-2982.2005.00679.x, 16185308.
30. Yang Q, Wu ZZ, Li X, Li ZW, Wei JB, Hu QS. Modulation by oxytocin of ATP-activated currents in rat dorsal root ganglion neurons. Neuropharmacology 2002, 43:910-916. 10.1016/S0028-3908(02)00127-2, 12384176.
31. Rinaman L. Oxytocinergic inputs to the nucleus of solitary tract and dorsal motor nucleus of the vagus in neonatal rats. J Comp Neurol 1998, 399:101-109. 10.1002/(SICI)1096-9861(19980914)399:1<101::AID-CNE8>3.0.CO;2-5, 9725704.
32. Larcher A, Neculcea J, Chu K, Zingg HH. Effects of retinoic acid and estrogens on oxytocin gene expression in the rat uterus: in vitro and in vivo studies. Mol Cell Endocrinol 1995, 114:69-76. 10.1016/0303-7207(95)03643-L, 8674853.
33. Feng M, Qin J, Wang S, Xie D, Wang PS, Liu C. Estradiol upregulates the expression of oxytocin receptor in colon in rats. Am J Physiol Endocrinol Metab 2009, 296:E1059-1066. 10.1152/ajpendo.90609.2008, 19258489.
34. Leake RD, Weitzman RE, Glatz TH, Fisher DA. Plasma oxytocin concentrations in men, nonpregnant women, and pregnant women before and during spontaneous labor. J Clin Endocrinol Metab 1981, 53:730-733. 10.1210/jcem-53-4-730, 7287862.
35. Agreus L, Svärdsudd K, Nyren O, Tibblin G. Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology 1995, 109:671-680. 10.1016/0016-5085(95)90373-9, 7657095.
36. Uvnäs-Moberg K, Arn I, Theorell T, Jonsson C-O. Gastrin, somatostatin and oxytocin levels in patients with functional disorders of the gastrointestinal tract and their response to feeding and interaction. J Psychosom Res 1991, 35:525-533. 10.1016/0022-3999(91)90047-R, 1681097.
37. Cui N, Wu BP, Wu SZ. Association of peripheral blood estradiol, progesterone and testosterone levels with irritable bowel syndrome. Nan Fang Yi Ke Da Xue Xue Bao 2006, 26:367-368.
38. Koohi MK, Walther N, Ivell R. A novel molecular assay to discriminate transcriptional effects caused by xenoestrogens. Mol Cell Endocrinol 2007, 276:45-54. 10.1016/j.mce.2007.06.008, 17716812.
39. Sahi T. Genetics and epidemiology of adult-type hypolactasia. Scand J Gastroenterol Suppl 1994, 202:7-20. 10.3109/00365529409091740, 8042019.